͵͵

Feature

From CRISPR to glowing proteins to optogenetics

Scientists’ most powerful technologies have been borrowed from nature
Marc Zimmer
By Marc Zimmer
Sept. 12, 2021

Today big, game-changing ideas are less common. New and improved techniques are the . They allow scientists — — to do our experiments faster than before, and they shine light on areas of science hidden to our predecessors.

Jellyfish-445x297.jpg
Crystal jellyfish contain glowing proteins that scientists repurpose for an endless
array of studies.

Three cutting-edge techniques — the gene-editing tool , and — were all inspired by nature. Biomolecular tools that have worked for bacteria, jellyfish and algae for millions of years are now being used in medicine and biological research. Directly or indirectly, they will change the lives of everyday people.

Bacterial defense systems as genetic editors

Bacteria and viruses battle themselves and one another. They are at constant biochemical war, .

One of the weapons that bacteria have in their arsenal is the . It is a genetic library consisting of short repeats of DNA gathered over time from hostile viruses, paired with a protein called Cas that can cut viral DNA as if with scissors. In the natural world, when bacteria are attacked by viruses whose DNA has been stored in the CRISPR archive, the CRISPR-Cas system hunts down, cuts and destroys the viral DNA.

Scientists have repurposed these weapons for their own use, with groundbreaking effect. Jennifer Doudna, a biochemist based at the University of California, Berkeley, and French microbiologist Emmanuelle Charpentier shared the for .

Emmanuelle_Charpentier_and_Jennifer_Doudna-890x422.jpg
French microbiologist Emmanuelle Charpentier (left) and U.S. biochemist Jennifer Doudna shared the 2020 Nobel Prize in Chemistry for development of the CRISPR–Cas gene editing technique.

The has provided a nearly complete genetic sequence for humans and given scientists a template to sequence all other organisms. However, before CRISPR–Cas, we researchers didn’t have the tools to easily access and edit the genes in living organisms. Today, thanks to CRISPR-Cas, lab work that used to take months and years and cost hundreds of thousands of dollars can be done in less than a week for just a few hundred dollars.

There are more than 10,000 genetic disorders caused by mutations that occur on only one gene, the . They affect millions of people. , and are among the most well-known of these disorders. These are all obvious targets for CRISPR therapy because it is much simpler to fix or replace just one defective gene rather than needing to correct errors on multiple genes.

For example, in preclinical studies, an encapsuled CRISPR system into patients born with a rare genetic disease, , that causes fatal nerve and heart conditions. Preliminary results from the study demonstrated directly into patients in such a way that it can find and edit the faulty genes associated with a disease. In the six patients included in this landmark work, the encapsuled CRISPR–Cas minimissiles reached their target genes and did their job, causing a significant drop in a associated with the disease.

Jellyfish light up the microscopic world

The , which drifts aimlessly in the northern Pacific, has no brain, no anus and no poisonous stingers. It is an unlikely candidate to ignite a revolution in biotechnology. Yet on the periphery of its umbrella, it has about 300 photo-organs that give off pinpricks of green light that have changed the way science is conducted.

This bioluminescent light in the jellyfish stems from a luminescent protein called aequorin and a fluorescent molecule called , or GFP. In modern biotechnology GFP acts as a molecular lightbulb that can be fused to other proteins, allowing researchers to track them and to see when and where proteins are being made in the cells of living organisms. Fluorescent protein technology is used in thousands of labs every day and has resulted in the awarding of two Nobel Prizes, and the . And fluorescent proteins have now been found in .

Green-fluorescent-protein-445x445.jpg
National Institute of General Medical Sciences/NIH
Martin Chalfie, Roger Y. Tsien and Osamu Shimomura shared the 2008 Nobel Prize
in Chemistry for their groundbreaking work on green fluorescent protein.

This technology proved its utility once again when researchers created genetically modified . The resulting fluorescence makes it possible to follow the path of the viruses as they enter the respiratory system and bind to surface cells with hairlike structures.

Algae let us play the brain neuron by neuron

When algae, which depend on sunlight for growth, are placed in a large aquarium in a darkened room, they swim around aimlessly. But if a lamp is turned on, the algae will swim toward the light. The single-celled — so named for the whiplike appendages they use to move around — don’t have eyes. Instead, they have a structure called an eyespot that distinguishes between light and darkness. The eyespot is studded with .

In the early 2000s, that when they genetically inserted these channelrhodopsins into the nerve cells of any organism, illuminating the channelrhodopsins with blue light caused neurons to fire. This technique, known as optogenetics, involves inserting the algae gene that makes channelrhodopsin into neurons. When a pinpoint beam of blue light is shined on these neurons, the channelrhodopsins open up, calcium ions flood through the neurons and the neurons fire.

Using this tool, scientists can stimulate groups of neurons selectively and repeatedly, thereby gaining a more precise understanding of which neurons to target to treat specific disorders and diseases. Optogenetics might hold the key to treating debilitating and deadly brain diseases, such as Alzheimer’s and Parkinson’s.

Amyloid-plaques-890x501.jpg
National Institute on Aging/NIH
Optogenetics could help treat Alzheimer’s disease, which is characterized by the buildup of misfolded proteins called amyloid plaques.

But optogenetics isn’t only useful for understanding the brain. Researchers have used optogenetic techniques and have found promising results in clinical trials using optogenetics on patients with , a group of genetic disorders that break down retinal cells. And in mouse studies, the technique has been used to and .

What else lies within nature’s toolbox?

What undiscovered techniques does nature still hold for us?

According to , people represent just 0.01% of all living things by mass but have caused the loss of 83% of all wild mammals and half of all plants in our brief time on Earth. By annihilating nature, humankind might be losing out on new, powerful and life-altering techniques without having even imagined them.

After all, no one could have foreseen that the discovery of three groundbreaking processes derived from nature could change the way science is done.The Conversation

This article is republished from under a Creative Commons license. Read the .

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition weekly.

Learn more
Marc Zimmer
Marc Zimmer

Marc Zimmer is the Jean C. Tempel '65 professor of chemistry at Connecticut College. He has published five books and written articles on science and medicine for publications such as the Los Angeles Times, USA Today and the Huffington Post.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Transforming learning through innovation and collaboration
Award

Transforming learning through innovation and collaboration

Nov. 22, 2024

Neena Grover will receive the William C. Rose Award for Exemplary Contributions to Education at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.

Guiding grocery carts to shape healthy habits
Award

Guiding grocery carts to shape healthy habits

Nov. 21, 2024

Robert “Nate” Helsley will receive the Walter A. Shaw Young Investigator in Lipid Research Award at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.

Quantifying how proteins in microbe and host interact
Journal News

Quantifying how proteins in microbe and host interact

Nov. 20, 2024

“To develop better vaccines, we need new methods and a better understanding of the antibody responses that develop in immune individuals,” author Johan Malmström said.

Leading the charge for gender equity
Award

Leading the charge for gender equity

Nov. 19, 2024

Nicole Woitowich will receive the ASBMB Emerging Leadership Award at the 2025 ASBMB Annual meeting, April 12–15 in Chicago.

CRISPR gene editing: Moving closer to home
News

CRISPR gene editing: Moving closer to home

Nov. 17, 2024

With the first medical therapy approved, there’s a lot going on in the genome editing field, including the discovery of CRISPR-like DNA-snippers called Fanzors in an odd menagerie of eukaryotic critters.

Finding a missing piece for neurodegenerative disease research
News

Finding a missing piece for neurodegenerative disease research

Nov. 16, 2024

Ursula Jakob and a team at the University of Michigan have found that the molecule polyphosphate could be what scientists call the “mystery density” inside fibrils associated with Alzheimer’s, Parkinson’s and related conditions.